Caligan Partners LP - May 6, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
10%+ Owner
Signature
Caligan Partners LP, By: /s/ David Edward Johnson, Partner
Stock symbol
LAB
Transactions as of
May 6, 2022
Transactions value $
$1,406,715
Form type
4
Date filed
5/10/2022, 09:03 PM
Previous filing
May 2, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock, $0.001 par value per share (Common Stock) Purchase $1.34M +463K +4.89% $2.90 9.95M May 6, 2022 See footnote F1, F2
transaction LAB Common Stock Purchase $63K +25K +0.25% $2.52 9.97M May 10, 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson (together with Caligan, the "Reporting Persons") is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
F2 The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Remarks:

The Reporting Persons disclaim beneficial ownership in the securities reported on this Form 4 except to the extent of his or its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that any of the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose.